Employment Screening Platform HireRight Prices US$422 Million IPO

Pre-employment background screening firm HireRight (NYSE: HRT) started publicly trading on the New York Stock Exchange today. The firm’s initial public offering is looking to raise US$422.22 million.

The offering will be conducted through the issuance of 22.22 million common shares selling at US$19.00 per share.

The company granted the underwriters a 30-day over-allotment option to purchase additional 3.33 million common shares at the same IPO price. Credit Suisse and Goldman Sachs & Co. are all acting as lead bookrunners for the said offering.

The firm also relayed that it intends to use the offering proceeds on repaying indebtedness, unwinding certain interest rate swaps, and for general corporate purposes, including continued investment in operating systems and technologies.

The offering is expected to close on November 2, 2021, subject to customary closing conditions.

The platform provides background screening services for potential job candidates for more than 40,000 customers across the globe. The firm said that it has screened over 20 million job applicants, employees, and contractors for its customers in 2020.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Why Industrial Demand Is Changing the Silver Market | David Morgan

Gold and Silver Delivery Is Exposing the Paper Market | Andy Schectman

Recommended

Steadright To Acquire 75% Interest In Moroccan Copper-Lead-Silver Project

Nations Royalty Names Derrick Pattenden As President And CEO

Related News

Biotech Firm Blue Water Vaccines Prices US$20 Million IPO

Biopharmaceutical company Blue Water Vaccines, Inc. (Nasdaq: BWV) began trading on the Nasdaq Capital Market...

Monday, February 21, 2022, 04:33:00 PM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

HempFusion Files For US$17 Million Initial Public Offering

HempFusion Wellness, the CBD firm that caused much excitement last year when it conducted a...

Thursday, October 22, 2020, 10:32:49 AM

New York-Based Bank Hanover Bancorp Prices US$26.8 Million IPO

New-York headquartered bank conglomerate Hanover Bancorp, Inc. (Nasdaq: HNVR) began trading on the Nasdaq Global...

Thursday, May 12, 2022, 02:24:00 PM

Singapore-Based SPAC RF Acquisition Prices US$100 Million IPO

Special purpose acquisition company RF Acquisition Corp. (Nasdaq: RFACU) started trading its securities on the...

Thursday, March 24, 2022, 02:25:00 PM